Mindray DS USA, Inc. dba Mindray North America recalls
3 notices naming Mindray DS USA, Inc. dba Mindray North America as the recalling firm, since October 1, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Mindray DS USA, Inc. dba Mindray North America: Hardware configuration of the BeneVision Central Monitoring System
Hazard (FDA): When the Worstation of the BeneVision DMS has a specific hardware configuration, the computer may experience audio playback failure or screen freezing.
FDAMedical devices
Mindray DS USA, Inc. dba Mindray North America: Sevoflurane and 1 more
Hazard (FDA): Potential for anesthesia leakage.
FDAMedical devices
Mindray DS USA, Inc. dba Mindray North America: BeneVision N1 Patient Monitor
Hazard (FDA): Potential for activation of an abnormal alarm pause.
FDAMedical devices